Zhengguo Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer (NCT06827080) | Zhengguo Chen | 2025-02-11 |
Track Zhengguo Chen automatically
Every clearance here is in the API, with alerts when new ones post.